SPX3,821.55-78.56 -2.01%
DIA309.34-5.02 -1.60%
IXIC11,181.54-343.01 -2.98%

Johnson & Johnson Unit Janssen Says Early Trial Data Shows Positive Results for Teclistamab to Treat Plasma Cell Cancer

MT Newswires · 06/10/2022 08:18

Please log in to view news